Isofol Medical AB (ISOFOL) — Working Capital to Net Assets Ratio
Isofol Medical AB (ISOFOL) has a Working Capital to Net Assets ratio of 100.6% as of December 2025. Working capital of Skr108.48 Million (current assets of Skr129.40 Million minus current liabilities of Skr20.91 Million) is measured against net assets of Skr107.87 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Isofol Medical AB (ISOFOL) balance sheet quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Isofol Medical AB Working Capital to Net Assets (2011–2025)
This chart shows how Isofol Medical AB's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2011 to 2025. As of December 2025, the ratio stands at 100.6%, reflecting working capital of Skr108.48 Million against net assets of Skr107.87 Million SEK. Check ISOFOL intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Isofol Medical AB (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Isofol Medical AB from 2011 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Isofol Medical AB market capitalisation.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 100.6% | Skr108.48 Million | Skr107.87 Million | Skr129.40 Million | Skr20.91 Million | ▼ -0.3 pp |
| 2024 | 100.8% | Skr78.59 Million | Skr77.94 Million | Skr98.42 Million | Skr19.82 Million | ▲ +0.1 pp |
| 2023 | 100.7% | Skr122.34 Million | Skr121.43 Million | Skr140.59 Million | Skr18.25 Million | ▲ +0.5 pp |
| 2022 | 100.3% | Skr158.91 Million | Skr158.48 Million | Skr209.45 Million | Skr50.54 Million | ▲ +2.4 pp |
| 2021 | 97.9% | Skr311.59 Million | Skr318.23 Million | Skr394.61 Million | Skr83.02 Million | ▲ +8.2 pp |
| 2020 | 89.7% | Skr59.72 Million | Skr66.57 Million | Skr139.84 Million | Skr80.12 Million | ▼ -3.9 pp |
| 2019 | 93.6% | Skr98.22 Million | Skr104.91 Million | Skr137.02 Million | Skr38.80 Million | ▼ -4.8 pp |
| 2018 | 98.5% | Skr260.92 Million | Skr265.01 Million | Skr284.46 Million | Skr23.54 Million | ▼ -1.4 pp |
| 2017 | 99.9% | Skr342.55 Million | Skr343.03 Million | Skr360.80 Million | Skr18.24 Million | ▲ +9.1 pp |
| 2016 | 90.8% | Skr5.54 Million | Skr6.10 Million | Skr22.33 Million | Skr16.79 Million | ▲ +37.7 pp |
| 2015 | 53.0% | Skr701.00K | Skr1.32 Million | Skr9.16 Million | Skr8.46 Million | ▼ -36.0 pp |
| 2011 | 89.0% | Skr7.02 Million | Skr7.89 Million | Skr9.51 Million | Skr2.49 Million | — |